Relationship between Volatile Anesthetics and Tumor Progression: Unveiling the Mystery

Abstract

A series of factors can be involved in the perioperative period to cause an increase in cancer-related mortality. Unfortunately, volatile anesthesia might aggravate the deleterious effects. In this article, we review the association of diverse volatile anesthetic agents with immune system and cancer cell biology, and examine the effects on angeogenesis and postoperative metastasis or recurrence. Isoflurane, haloflurane and enflurane enhance immunosuppression and upregulate hypoxia-inducible-factor 1 and matrix metalloproteinases, leading to the cancer malignant progression, whereas roles of desflurane and sevoflurane are still unclear. As the effects of volatile anesthetics on tumor immunity have been known, it will be beneficial for using selective drugs into anesthesia and operation in cancer patients.

Keywords

volatile anesthesia / metastasis / recurrence / immunosuppression / hypoxia-induciblefactor

References

[1] MelamedR, RosenneE, ShakharK, et al.. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: Suppression by surgery and the prophylactic use of beta-adrenergic and prostaglandin synthesis inhibitor. Brain Behav Immun, 2005, 19(2): 114-126

[2] YangQ, GodingSR, HoklandME, et al.. Antitumor activity of NK cells. Immunol Res, 2006, 36(1-3): 13-25

[3] ZamaiL, PontiC, MirandolaP, et al.. NK cells and cancer. J Immunol, 2007, 178(7): 4011-4016

[4] BrittendenJ, HeysSD, RossJ, et al.. Natural killer cells and cancer. Cancer, 1996, 77(7): 1226-1243

[5] Ben-EliyahuS, PageGG, YirmiyaR, et al.. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int J Cancer, 1999, 80(6): 880-888

[6] KodaK, SaitoN, TakiguchiN, et al.. Preoperative natural killer cell activity: correlation with distant metastases in curatively research colorectal carcinomas. Int Surg, 1997, 82(2): 190-193

[7] KodaK, SaitoN, OdaK, et al.. Natural killer cell activity and distant metastasis in rectal cancers treated surgically with and without neoadjuvant chemoradiotherapy. J Am Coll Surg, 2003, 197(2): 254-260

[8] SchantzSP, BrownBW, LiraE, et al.. Evidence for the role of natural immunity in the control of metastatic spread of head and neck cancer, 1987, 25(2): 141-148

[9] ShakharG, Ben-EliyahuS. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol, 1998, 160(7): 3251-3258

[10] PennI. The effect of immunosuppression on pre-existing cancers. Transplant Proc, 1993, 25(1Pt2): 1380-1382

[11] TavareAN, PerryNJ, BenzonanaLL, et al.. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer, 2012, 130(6): 1237-1250

[12] LoopT, Dovi-AkueD, FrickM, et al.. Volatile anesthetics induce caspase-dependent, mitochondriamediated apoptosis in human T lymphocytes in vitro. Anesthesiology, 2005, 102(6): 1147-1157

[13] WeiH, LiangG, YangH, et al.. The common inhalational anesthetic isofurane induces apoptosis via activation of inositol 1, 4, 5-trisphosphate receptors. Anesthesiology, 2008, 108(2): 251-260

[14] WooJH, BaikHJ, KimCH, et al.. Effect of Propofol and Desflurane on Immune Cell Populations in Breast Cancer Patients: A Randomized Trial. J Korean Med Sci, 2015, 30(10): 1503-8

[15] KotaniN, HashimotoH, SesslerDI, et al.. Intraoperative modulation of alveolar macrophage function during isoflurane and propofol anesthesia. Anesthesiology, 1998, 89(5): 1125-1132

[16] KotaniN, TakahashiS, SesslerDI, et al.. Volatile anesthetics augment expression of proinflammatory cytokines in rat alveolar macrophages during mechanical ventilation. Anesthesiology, 1999, 91(1): 187-197

[17] KotaniN, HashimotoH, SesslerDI, et al.. Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia. Anesth Analg, 1999, 89(5): 1250-1256

[18] MarkovicSN, MuraskoDM. Anesthesia inhibits interferon-induced natural killer cell cytotoxicity viainduction of CD8+ suppressor cells. Cell Immunol, 1993, 151(2): 474-480

[19] TavareAN, PerryNJ, BenzonanaLL, et al.. Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer, 2012, 130(6): 1237-1250

[20] MelamedR, Bar-YosefS, ShakharG, et al.. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg, 2003, 97(5): 1331-1339

[21] MitsuhataH, ShimizuR, YokoyamaMM. Suppressive effects of volatile anesthetics on cytokine release in human peripheral blood mononuclear cells. Int J Immunopharmacol, 1995, 17(6): 529-534

[22] FlondorM, HofstetterC, BoostKA, et al.. Isoflurane inhalation after induction of endotoxemia in rats attenuates the systemic cytokine response. Eur Surg Res, 2008, 40(1): 1-6

[23] Pirbudak CocelliL, UgurMG, KaradasliH. Comparison of effects of low fow sevofurane and desfurane anesthesia on neutrophil and T-cell populations. Curr Ther Res Clin Exp, 2012, 73(1-2): 41-51

[24] MöbertJ, ZahlerS, BeckerBF, et al.. Inhibition of neutrophil activation by volatile anesthetics decreases adhesion to cultured human endothelial cells. Anesthesiology, 1999, 90(5): 1372-1381

[25] KowalskiC, ZahlerS, BeckerBF, et al.. Halothane, isoflurane, and sevoflurane reduce postischemic adhesion of neutrophils in the coronary system. Anesthesiology, 1997, 86(1): 188-195

[26] HeindlB, ReichleFM, ZahlerS, et al.. Sevoflurane and isoflurane protect the reperfused guinea pig heart by reducing postischemic adhesion of polymorphonuclear neutrophils. Anesthesiology, 1999, 91(2): 521-530

[27] ChoJS, LeeMH, KimSI, et al.. The Effects of Perioperative Anesthesia and Analgesia on Immune Function in Patients Undergoing Breast Cancer Resection: A Prospective Randomized Study. Int J Med Sci, 2017, 14(10): 970-976

[28] TazawaK, KoutsogiannakiS, ChamberlainM, et al.. The effect of different anesthetics on tumor cytotoxicity by natural killer cells. Toxicol Lett, 2017, 266: 23-31

[29] InadaT, YamanouchiY, JomuraS, et al.. Effect of propofol and isoflurane anaesthesia on the immune response to surgery. Anaesthesia, 2004, 59(10): 954-959

[30] DeeganCA, MurrayD, DoranP, et al.. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery. Reg Anesth Pain Med, 2010, 35(6): 490-495

[31] SchneemilchCE, HachenbergT, AnsorgeS, et al.. Effects of different anaesthetic agents on immune cell function in vitro. Eur J Anaesthesiol, 2005, 22(8): 616-623

[32] GotoY, HoSL, McAdooJ, et al.. General versus regional anaesthesia for cataract surgery: effects on neutrophilapoptosis and the postoperative proinflammatory state. Eur J Anaesthesiol, 2000, 17(8): 474-480

[33] OhCS, LeeJ, YoonTG, et al.. Effect of Equipotent Doses of Propofol versus Sevoflurane Anesthesia on Regulatory T Cells after Breast Cancer Surgery. Anesthesiology, 2018, 129(5): 921-931

[34] GeneraliD, BerrutiA, BrizziM, et al.. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer. Clin Cancer Res, 2006, 12(15): 4562-4568

[35] RohwerN, LobitzS, DaskalowK, et al.. HIF-1alpha determines the metastatic potential of gastric cancer cells. Br J Cancer, 2009, 100(5): 772-781

[36] DaiC, GaoQ, QiuS, et al.. Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer, 2009, 9: 418

[37] BabaY, NoshoK, ShimaK, et al.. HIF1A Overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol, 2010, 176(5): 2292-2301

[38] OsadaR, HoriuchiA, KikuchiN, et al.. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor1alpha is an independent prognostic factor in ovarian carcinoma. Hum Pathol, 2007, 38(9): 1310-1320

[39] UnwithS, ZhaoH, HennahL, et al.. The potential role of HIF on tumor progression and dissemination. Int J Cancer, 2015, 136(11): 2491-2503

[40] HuangH, BenzonanaLL, ZhaoH, et al.. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer, 2014, 111(7): 1338-1349

[41] BenzonanaLL, PerryNJ, WattsHR, et al.. Isoflurane, a commonly used volatile anesthetic, enhances renal cancer growth and malignant potential via the hypoxiainducible factor cellular signaling pathway in vitro. Anesthesiology, 2013, 119(3): 593-605

[42] WangC, WeihrauchD, SchwabeD, et al.. Extracellular signalregulated kinases trigger isoflurane preconditioning concomitant with upregulation of hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in rats. Anesth Analg, 2006, 103(2): 281-288

[43] KawaraguchiY, HorikawaYT, MurphyAN, et al.. Volatile anesthetics protect cancer cells against tumor necrosis factor-related apoptosis-inducing ligandinduced apoptosis via caveolins. Anesthesiology, 2011, 115(3): 499-508

[44] KvolikS, Glavas-ObrovacL, BaresV, et al.. Effects of inhalation anesthetics halothane, sevoflurane, and isoflurane on human cell lines. Life Sci, 2005, 77(19): 2369-2383

[45] ShiQY, ZhangSJ, LiuL, et al.. Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxia-inducible factors in vitro. Br J Anaesth, 2015, 114(5): 825-830

[46] FerrellJK, CattanoD, BrownRE, et al.. The effects of anesthesia on the morphoproteomic expression of head and neck squamous cell carcinoma: a pilot study. Transl Res, 2015, 166(6): 674-682

[47] LiangH, YangCX, ZhangB, et al.. Sevoflurane suppresses hypoxia-induced growth and metastasis of lung cancer cells via inhibiting hypoxia-inducible factor-1α. J Anesth, 2015, 29(6): 821-830

[48] IwasakiM, ZhaoH, JafferT, et al.. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget, 2016, 7(18): 26042-26056

[49] LuoX, ZhaoH, HennahL, et al.. Impact of isoflurane on malignant capability of ovarian cancer in vitro. Br J Anaesth, 2015, 114(5): 831-839

[50] Müller-EdenbornB, Roth-ZgraggenB, BartnickaK, et al.. Volatile anesthetics reduce invasion of colorectal cancer cells through down-regulation of matrix metalloproteinase-9. Anesthesiology, 2012, 117(2): 293-301

[51] BonelloS, Za¨hringerC, BelAibaR, et al.. Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler Thromb Vasc Biol, 2007, 27(4): 755-761

[52] MaranchieJ, ZhanY. Nox4 is critical for hypoxiainducible factor 2-alpha transcriptional activity in von Hippel-Lindau-deficient renal cell carcinoma. Cancer Res, 2005, 65(20): 9190-9193

[53] MüllenheimJ, EbelD, FrässdorfJ, et al.. Isoflurane preconditions myocardium against infarction via release of free radicals. Anesthesiology, 2002, 96(4): 934-940

[54] HanouzJ, ZhuL, LemoineS, et al.. Reactive oxygen species mediate sevoflurane-and desflurane-induced preconditioning in isolated human right atria in vitro. Anesth Analg, 2007, 105(6): 1534-1539

[55] LooneyM, DoranP, BuggyDJ. Effect of anesthetic technique on serum vascular endothelial growth factor C and transforming growth factor beta in women undergoing anesthesia and surgery for breast cancer. Anesthesiology, 2010, 113(5): 1118-1125

[56] IwasakiM, ZhaoH, JafferT, et al.. Volatile anaesthetics enhance the metastasis related cellular signalling including CXCR2 of ovarian cancer cells. Oncotarget, 2016, 7(18): 26042-26056

[57] JunIJ, JoJY, KimJI, et al.. Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study. Sci Rep, 2017, 7(1): 14020

[58] ShapiroJ, JerskyJ, KatzavS, et al.. Anesthetic drugs accelerate the progression of postoperative metastases of mouse tumors. J Clin Invest, 1981, 68(3): 678-685

[59] MoudgilGC, SingalDP. Halothane and isoflurane enhance melanoma tumour metastasis in mice. Can J Anaesth, 1997, 44(1): 90-94

[60] EliasKM, KangS, LiuX, et al.. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol, 2015, 22(4): 1341-1348

[61] LiangH, YangCX, ZhangB, et al.. Sevoflurane attenuates platelets activation of patients undergoing lung cancer surgery and suppresses platelets-induced invasion of lung cancer cells. J Clin Anesth, 2016, 35: 304-312

[62] EcimovicP, McHughB, MurrayD, et al.. Effects of sevofurane on breast cancer cell function in vitro. Anticancer Res, 2013, 33(10): 4255-4260

[63] DeeganCA, MurrayD, DoranP, et al.. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth, 2009, 103(5): 685-690